Dr. Gymbro
←

#fatigue resistance

1 article
A bright, modern editorial photograph of a minimalist athletic studio with pale oak flooring and soft diffused daylight pouring in from tall windows on the left. In the foreground, slightly off-center to the right, a tall glass of deep magenta-crimson beetroot juice sits on a matte white concrete surface, condensation beading on the glass, a few fresh whole beets with leafy stems and one halved beet showing vivid concentric purple rings arranged beside it. Behind them, softly blurred with shallow depth of field, an athlete in neutral-toned athletic wear (charcoal and cream) crouches mid-prep, with slim black blood flow restriction cuff bands wrapped around the upper thighs. A clean wooden plyo box and a simple barbell rack are subtly visible in the background. A thin arc of chalk dust hangs in the air, suggesting a recent jump. The color palette is restrained and trendy: warm off-white, soft sage green, charcoal gray, with the beetroot magenta as the single bold accent. Composition follows a wide 16:9 landscape layout with generous negative space on the left third for title overlay. Lighting is natural, gentle, and slightly golden, with soft shadows and a subtle film-grain texture. The overall feel is a contemporary wellness and sports science magazine cover: clean, calm, sophisticated, tactile, with crisp detail on the juice and beets and a dreamy blur on the athlete.
science research

Jugo de remolacha + entrenamiento BFR: la ventaja del salto fatigado que no se tradujo en fuerza

BY DR. GYMBRO ·

Muchos creen que combinar jugo de remolacha con entrenamiento de restricción de flujo sanguíneo (BFR) potencia la fuerza. Un ensayo aleatorizado, doble ciego, muestra que ambos grupos aumentaron la fuerza, pero solo el que tomó jugo de remolacha mejoró significativamente la altura del salto con contramovimiento cuando estaba fatigado. El estudio utilizó 8 mmol de nitrato al día, una fase de carga de una semana y un programa BFR de cuatro semanas. Aquí tienes el protocolo, a quién puede interesar, a quién debería evitarlo y por qué un estudio con 20 participantes debe tomarse con cautela.

This page is available in